Crossmark

Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma

Published Online: 2021-08-30

Published Print: 2022-08

Authors

Kim, Ha Il https://orcid.org/0000-0002-5471-7790
Lim, Jihye

Shim, Ju Hyun https://orcid.org/0000-0002-7336-1371
Funding

Funding for this research was provided by:

National Research Foundation of Korea (NRF-2017R1E1A1A01074298)
License Information

Text and Data Mining valid from 2021-08-30

Version of Record valid from 2021-08-30
More Information

Article History

Received: 9 April 2021

Accepted: 4 July 2021

First Online: 30 August 2021

Declarations

:

: The authors declare no competing interests.

: This study was approved by the Institutional Review Board (IRB No. 2019-1573) of the Asan Medical Center, which waived the requirement for informed consent.

: Not required.

Document is current